Shanghai Pharmaceuticals Holding Co., Ltd
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
9.19 | 31.52 | -70.83% | 3.94 | +133.02% |
| P/S |
|
0.1331 | 3.23 | -95.88% |
|
|
| P/BV |
|
0.0607 | 3.36 | -98.19% |
|
|
| P/FCF |
|
0 | 21.22 | -100% |
|
|
| Ev/Ebitda |
|
12.31 | 10.23 | 20.42% |
|
|
| Ev/S |
|
0.5515 | 1.88 | -70.74% |
|
|
| Ev/FCF |
|
63.49 | 19.91 | 218.87% |
|
|
| E/P |
|
0 | 1.47 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
4.48 | 24.7 | -81.87% | 4.92 | -8.92% |
| ROE |
|
0.7745 | 13.11 | -94.09% |
|
|
| ROA |
|
0.2504 | 6.09 | -95.89% |
|
|
| ROIC |
|
0 | 15.56 | -100% |
|
|
| ROS |
|
1.45 | 12.44 | -88.34% |
|
|
| ROCE |
|
1.66 | 15.21 | -89.09% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
26.99 | 6.21 | 334.25% | 17.52 | +54.01% |
| Nеt Debt/Ebitda |
|
9.34 | -5.72 | -263.29% |
|
|
| Debt/Ratio |
|
0.209 | 0.213 | -1.85% |
|
|
| Debt/Equity |
|
2.16 | 12.49 | -82.75% |
|
|
| Debt/Net Income |
|
83.49 | 15.07 | 454.13% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
4.36 | 1.73 | 151.95% | 8.99 | -51.53% |
| Number of years of dividend growth |
|
1 | 1.21 | -17.44% | ||
| DSI |
|
0.7143 | 0.7783 | -8.23% |
|
|
| Average dividend growth |
|
-31 | -269.81 | -88.51% |
|
|
| Average percentage for 5 years |
|
8.99 | 2.8 | 220.81% |
|
|
| Average percentage for payments |
|
102.56 | 247.86 | -58.62% |
|
|
| Difference from average difference in sector |
|
2.63 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-80.15 | 132.71 | -160.39% | ||
| Growth impulse Ebitda in 5 years |
|
-83.73 | 100.7 | -183.15% | ||
| Growth impulse Net Income in 5 years |
|
-86.87 | 116.53 | -174.55% | ||
| Growth impulse FCF in 5 years |
|
-90.17 | 88.28 | -202.14% | ||
| Growth impulse EPS in 5 years |
|
-89.94 | 217.84 | -141.29% |
IP Score
3.66/10
